Datasheet | November 6, 2024

NB-KUL™ DF Cryopreservation Medium: Custom DMSO-Free And Chemically-Defined Cryomedia

NB-KUL

Many cryopreservation media available today contain DMSO, a cryoprotectant that, despite its effectiveness, poses challenges due to its cytotoxicity and potential adverse effects on patients in cell and gene therapies. Additionally, most cryomedia on the market come in fixed formulations and packaging, limiting developers’ flexibility to adapt these products to their specific needs.

Nucleus Biologics’ QuickStart Media™ platform addresses these issues by offering NB-KUL DF, a DMSO-free, customizable cryopreservation solution. This platform provides users with convenient and cost-effective customization options to tailor media formulations to support various cell types used in research and therapy, such as T cells, NK cells, and stem cells.

With the platform, developers can order ready-to-use (RUO) samples of NB-KUL DF to begin optimizing media formulations. The platform allows users to test initial samples, review performance data, and collaborate with the Nucleus Biologics team to adjust the media composition as needed. This streamlined process helps researchers save time and resources while developing specialized media tailored for their cell therapy projects.

In addition to being DMSO-free, NB-KUL DF is xeno-free, serum-free, and sterile filtered, with a liquid format and a stable pH range, making it ideal for sensitive applications. Overall, QuickStart Media™ accelerates media optimization, ensuring cell therapy researchers have access to safer and customizable cryopreservation solutions tailored to their therapeutic goals.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online